Tested Applications
| Positive IHC detected in | human ovary tumor tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
60261-1-Ig targets MUC16/CA125 in IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | mucin 16, cell surface associated |
| Calculated Molecular Weight | 1519 kDa |
| GenBank Accession Number | NM_024690 |
| Gene Symbol | MUC16 |
| Gene ID (NCBI) | 94025 |
| RRID | AB_2881382 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein G purification |
| UNIPROT ID | Q8WXI7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
MUC16, also named as CA125, is thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces. It is a serum marker that is used routinely in gynecologic practice to monitor patients with ovarian cancer. Most biochemical studies have concluded that MUC16 is a high molecular mass glycoprotein, although estimates of its size range from 200 to 2000 kDa with smaller "subunits" being described by some investigators. The antibody recognizes the C-term of MUC16.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for MUC16/CA125 antibody 60261-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
MUC16/CA125 Monoclonal antibody, catalog number 60261-1-Ig, has 2 citations in total. Both citations appear in cancer research publications. The journals featuring this antibody are Cancer Letters and International Journal of Oncology. The associated research fields include pancreatic cancer biology and tumor immunology, specifically studies on MUC16 C-terminal-induced tumor-derived IL-6 secretion and Treg enrichment in pancreatic cancer, as well as research on the Lewis antigen-negative aggressive subgroup of pancreatic cancer. All applications were IHC (immunohistochemistry) performed on human samples.
| Species | Application | Title |
|---|---|---|
Cancer Lett MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer. | ||



